首页|期刊导航|口腔疾病防治|中性粒细胞胞外诱捕网相关基因介导口腔鳞状细胞癌发病机制及预后标志物的研究

中性粒细胞胞外诱捕网相关基因介导口腔鳞状细胞癌发病机制及预后标志物的研究OA

Research on the mechanism of neutrophil extracellular trap-related genes mediating the onset of oral squa-mous cell carcinoma and their prognostic markers

中文摘要英文摘要

目的 探讨中性粒细胞胞外诱捕网(NETs)相关基因在口腔鳞状细胞癌(OSCC)中的预后价值及生物学功能.方法 从癌症基因组图谱数据库(TCGA)和基因表达谱数据库(GEO)获取OSCC的333例转录组数据及6例单细胞测序数据.基于69个NETs相关基因集,采用单因素Cox与Lasso-Cox回归构建OSCC预后风险模型,通过Kaplan-Meier分析和受试者工作特征(ROC)曲线评估模型效能,并进行风险评分与列线图分析.进一步探究NETs风险评分与血管生成、上皮间充质转化(EMT)及细胞周期的关系.采用富集分析注释相关通路功能.通过Kaplan-Meier分析筛选预后关键基因,并进行药物预测与分子对接验证候选靶点.运用单细胞RNA测序分析关键基因组织蛋白酶G(CTSG)在肿瘤微环境(TME)中的表达特征,利用TCGA泛癌及OSCC数据分析CTSG在肿瘤与正常组织中的表达差异,最后采用组织芯片进行免疫组化实验,在蛋白水平验证CTSG的表达.结果 成功构建基于6个NETs相关基因(F3、AKT1、CTSG、VNN3、MPO、IL17A)的风险预后模型.高风险组患者总生存期(OS)显著缩短(P<0.000 1).模型在预测1、3、5年生存率的ROC曲线下面积(AUC)分别为0.718、0.820和0.805,NETs风险评分被确立为独立预后因素(P<0.001),且列线图校准良好.NETs 风险评分与血管生成(r=-0.20,P<0.001)、EMT(r=0.17,P<0.01)、G1/S周期(r=0.11,P<0.05)及 G2/M 周期(r=0.17,P<0.01)相关.基因集富集分析(GSEA)提示高风险组富集于基底细胞癌等通路,低风险组富集于α-亚麻酸代谢等通路(P<0.05).Kaplan-Meier分析提示CTSG低表达患者预后较差(P<0.001);分子对接显示CTSG与谷胱甘肽结合良好(结合能:-7.4 kcal/mol);单细胞分析表明CTSG在肥大细胞亚群中高表达,在恶性细胞中低表达(P<0.001);TCGA泛癌分析表明CTSG在包括OSCC在内的多种癌组织中低表达(P<0.05);免疫组化证实癌组织中CTSG表达低于癌旁组织(P<0.01).结论 本研究构建的NETs相关基因预后模型具有良好的预测性能.CTSG被鉴定为关键预后基因,为OSCC预后评估与靶向治疗提供了新的生物标志物和潜在干预靶点.

Objective To investigate the prognostic significance and biological functions of neutrophil extracellular traps(NETs)related genes in oral squamous cell carcinoma(OSCC).Methods A total of 333 transcriptome datasets and 6 single-cell sequencing datasets of OSCC were retrieved from the Cancer Genome Atlas(TCGA)and Gene Expres-sion Omnibus(GEO)databases.Based on 69 NETs related gene sets,univariate Cox and Lasso-Cox regression were used to construct a prognostic risk model for OSCC.The model's efficacy was evaluated through Kaplan-Meier analysis and receiver operating characteristic(ROC)curves,and risk scoring and nomogram analysis were conducted.Further,the relationship between NETs risk scores and angiogenesis,epithelial-mesenchymal transition(EMT),and cell cycle was explored.Enrichment analysis was performed to annotate the functional characteristics of relevant pathways.Kaplan-Meier analysis was employed to screen for prognostic key genes.Candidate targets were validated through drug prediction and molecular docking assays.Single-cell RNA sequencing was utilized to characterize the expression profile of the key gene cathepsin G(CTSG)within the tumor microenvironment(TME).Using pan-cancer and OSCC related data retrieved from the TCGA database,we analyzed the differences in CTSG expression between tumor tissues and nor-mal tissues.Subsequently,immunohistochemical staining experiments were performed on tissue microarrays to validate its expression at the protein level.Results A prognostic risk model based on six NETs related genes(F3,AKT1,CTSG,VNN3,MPO,and IL17A)was successfully established.Patients in the high-risk group exhibited significantly shorter overall survival(OS)(P<0.000 1).The area under the ROC curve(AUC)of the established model for predicting 1-,3-,and 5-year overall survival(OS)rates was 0.718,0.820,and 0.805,respectively.The NETs related risk score was identified as an independent prognostic factor(P<0.001),with the constructed nomogram demonstrating good calibra-tion.The NETs related risk score correlated with angiogenesis(r=-0.20,,P<0.001),EMT(r=0.17,P<0.01),G1/S phase transition(r=0.11,P<0.05),and G2/M phase transition(r=0.17,P<0.01).GSEA(gene set enrichment analy-sis)revealed that the high-risk group was significantly enriched in pathways including basal cell carcinoma,whereas the low-risk group exhibited significant enrichment in pathways such as alpha-linolenic acid metabolism(P<0.05).Kaplan-Meier analysis revealed that patients with low expression of CTSG had a poorer prognosis(P<0.001).Molecular dock-ing assays demonstrated a stable binding interaction between CTSG and glutathione(binding energy:-7.4 kcal/mol).Single-cell RNA sequencing analysis further showed that CTSG was highly expressed in mast cell subsets but weakly expressed in malignant cells(P<0.001).TCGA pan-cancer analysis revealed that CTSG is underexpressed in multiple cancer tissues,including OSCC(P<0.05).Immunohistochemical staining confirmed that CTSG protein expression was lower in tumor tissues than in paracancerous tissues(P<0.01).Conclusion The NETs related prognostic model es-tablished in this study exhibits robust predictive performance.CTSG was identified as a key prognostic gene,thereby providing a novel biomarker and potential therapeutic target for prognostic evaluation and targeted therapy of OSCC.

于浩洋;张瑞;宋红权

哈尔滨医科大学口腔医学院,黑龙江哈尔滨(150000)黑龙江省医院南岗院区口腔科,黑龙江哈尔滨(150000)哈尔滨医科大学附属第一医院口腔颌面外科,黑龙江哈尔滨(150000)

医药卫生

口腔鳞状细胞癌中性粒细胞胞外诱捕网预后模型风险评分生物标志物组织蛋白酶G单细胞分析肿瘤微环境预后评估

oral squamous cell carcinomaneutrophil extracellular trapsprognostic modelrisk scorebio-markercathepsin Gsingle-cell analysistumor microenvironmentprognostic evaluation

《口腔疾病防治》 2026 (4)

349-366,18

黑龙江省自然科学基金项目(LH2022H056)黑龙江省博士后科研启动基金(LBH-Q21143) This study was supported by the grants from Natural Science Foundation of Heilongjiang Province of China(No.LH2022H056)Postdoctoral Scientific Research Developmental Fund of Heilongjiang Province of China(No.LBH-Q21143).

10.12016/j.issn.2096-1456.202550548

评论